If you caught President Biden’s first State of the Union Address last week, you know that bringing drug prices down is at the forefront of his administration’s goals. In that same vein, a recent KIMT3 News article discussed a new non-profit organization that aims to make insulin more accessible for Americans. The company is called Civica Rx, and it was co-rounded by the Mayo Clinic. It plans to manufacture and distribute a variety of insulin products including Glargine, Lispro, and Apsart, which are alternatives for Lantus, Humalog, and Novolog, respectively.
Mayo-Backed Nonprofit to Make Cheaper Insulin
Civica Rx will manufacture the majority of its low-cost insulin products in the United States.
Mar 7, 2022
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Researched List: Blister Machines for Life Sciences
Need a blister machine for life sciences packaging? Our curated list features companies serving pharmaceutical, medical device, nutraceutical, and cosmetic industries. Download to access company names, locations, machine specifications, descriptions, and more.
Download Now
